Pere Puigserver

Pere Puigserver

Auto-generated profile, based on publicly available information

Pere Puigserver

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2007 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
ZGZachary Gerhart‐Hines
Zachary Gerhart‐Hines
JRJoseph T Rodgers
Joseph T Rodgers
OBOlivia Bare
Olivia Bare
CLCarles Lerin
Carles Lerin
SKSeung‐Hee Kim
Seung‐Hee Kim
PPPere Puigserver
Pere Puigserver
In mammals, maintenance of energy and nutrient homeostasis during food deprivation is accomplished through an increase in mitochondrial fatty acid oxidation in peripheral tissues. An important component that drives this cellular oxidative process is the transcriptional coactivator PGC‐1α. Here, we show that fasting induced PGC‐1α deacetylation in skeletal muscle and that SIRT1 deacetylation of PGC‐1α is required for activation of mitochondrial fatty acid oxidation genes. Moreover, expression of the acetyltransferase, GCN5, or the SIRT1 inhibitor, nicotinamide, induces PGC‐1α acetylation and decreases expression of PGC‐1α target genes in myotubes. Consistent with a switch from glucose to fatty acid oxidation that occurs in nutrient deprivation states, SIRT1 is required for induction and maintenance of fatty acid oxidation in response to low glucose concentrations. Thus, we have identified SIRT1 as a functional regulator of PGC‐1α that induces a metabolic gene transcription program of mitochondrial fatty acid oxidation. These results have implications for understanding selective nutrient adaptation and how it might impact lifespan or metabolic diseases such as obesity and diabetes.

1 March 2013 in Cancer Cell
Verified
Journal Article
Closed access
FVFrancisca Vazquez
Francisca Vazquez
JLJi-Hong Lim
Ji-Hong Lim
HCHelen Chim
Helen Chim
KBKavita Bhalla
Kavita Bhalla
GGGeoff Girnun
Geoff Girnun
PPPere Puigserver
Pere Puigserver

3 September 2017 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MHMaximilian Hatting
Maximilian Hatting
CTClint D.J. Tavares
Clint D.J. Tavares
KSKfir Sharabi
Kfir Sharabi
ARAmy K. Rines
Amy K. Rines
PPPere Puigserver
Pere Puigserver

26 November 2007 in FEBS Letters
Verified
Journal Article
Closed access
JRJoseph T. Rodgers
Joseph T. Rodgers
CLCarles Lerin
Carles Lerin
ZGZachary Gerhart-Hines
Zachary Gerhart-Hines
PPPere Puigserver
Pere Puigserver

31 July 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JRJoseph T. Rodgers
Joseph T. Rodgers
PPPere Puigserver
Pere Puigserver
In the fasted state, induction of hepatic glucose output and fatty acid oxidation is essential to sustain energetic balance. Production and oxidation of glucose and fatty acids by the liver are controlled through a complex network of transcriptional regulators. Among them, the transcriptional coactivator PGC-1α plays an important role in hepatic and systemic glucose and lipid metabolism. We have previously demonstrated that sirtuin 1 (SIRT1) regulates genes involved in gluconeogenesis through interaction and deacetylation of PGC-1α. Here, we show in vivo that hepatic SIRT1 is a factor in systemic and hepatic glucose, lipid, and cholesterol homeostasis. Knockdown of SIRT1 in liver caused mild hypoglycemia, increased systemic glucose and insulin sensitivity, and decreased glucose production. SIRT1 knockdown also decreased serum cholesterol and increased hepatic free fatty acid and cholesterol content. These metabolic phenotypes caused by SIRT1 knockdown tightly correlated with decreased expression of gluconeogenic, fatty acid oxidation and cholesterol degradation as well as efflux genes. Additionally, overexpression of SIRT1 reversed many of the changes caused by SIRT1 knockdown and depended on the presence of PGC-1α. Interestingly, most of the effects of SIRT1 were only apparent in the fasted state. Our results indicate that hepatic SIRT1 is an important factor in the regulation of glucose and lipid metabolism in response to nutrient deprivation. As these pathways are dysregulated in metabolic diseases, SIRT1 may be a potential therapeutic target to control hyperglycemia and hypercholesterolemia.

12 August 2016 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
PDF file
ARAmy K. Rines
Amy K. Rines
KSKfir Sharabi
Kfir Sharabi
CTClint D. J. Tavares
Clint D. J. Tavares
PPPere Puigserver
Pere Puigserver